Gastroenterology Group of Rochester, LLP

Rochester, New York 14618

3 studies enrolling now · 4 studies all time

What they study most

Clostridium Difficile Infection, Eosinophilic Esophagitis (EoE), Fecal Microbiota Transplantation, Gut Microbiome, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care — Recruiting now
• Fecal Microbiota Transplant National Registry — Recruiting now